2023-11-14T06:56:20-00:00 2022-12-31 821650312 Alta CPA Group 59 Franklin St 2nd Floor Annapolis MD 21401 990 2022-01-01 371578088 METAVIVOR RESEARCH AND SUPPORT INC META 8188601226 1783 FOREST DRIVE ANNAPOLIS MD 21401 JAMIL RIVERS MEMBER 8188601226 2023-11-14 true JAMIL RIVERS XXX-XX-XXXX Jeffrey Griffith P01081433 4103495101 2023-11-14 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z JAMIL RIVERS 1783 FOREST DRIVE STE 184 ANNAPOLIS MD 21401 7110848 false X WWW.METAVIVOR.ORG X 2009 MD TO FUND STAGE IV METASTATIC BREAST CANCER MBC RESEARCH TO TRANSITION THE DISEASE FROM TERMINAL TO CHRONIC YET MANAGEABLE WITH A GOOD QUALITY OF LIFE, CONTINUED ON SCHEDULE O 14 14 3 105 0 5723827 6133635 0 53134 138655 33121 472669 5810082 6744959 5146847 5750000 0 191086 194540 0 4213 210695 299888 5548628 6244428 261454 500531 15087139 17442424 13303024 15370996 1784115 2071428 TO FUND STAGE IV METASTATIC BREAST CANCER MBC RESEARCH TO TRANSITION THE DISEASE FROM TERMINAL TO CHRONIC YET MANAGEABLE WITH A GOOD QUALITY OF LIFE, CONTINUED ON SCHEDULE O false false 6016909 5750000 THIS YEAR METAVIVOR AWARDED OR PAID STAGE IV METASTATIC BREAST CANCER RESEARCH GRANTS TO VIRGINIA COMMONWEALTH UNIVERSITY, NATIONAL CANCER INSTITUTE, UNIVERSITY OF PITTSBURGH, ICAHN SCHOOL OF MEDICINE, UNIVERSITY OF MINNESOTA, UNIVERSITY OF ALABAMA, BOSTON MEDICAL CENTER, CEDARS SINAI, UNIVERSITY OF COLORADO, DARTMOUTH COLLEGE, HEALTH RESEARCH INSTITUTE, UNIVERISTY OF UTAH-HUNTSMAN, UNIVERSITY OF VIRGINIA, WAKE FOREST UNIVERSITY, STATE UNIVERSITY OF NEW YORK, UNIVERSITY OF MARYLAND, UNIVERSITY OF KANSAS, NEW MEXICO SCHOOL OF MEDICINE, UNIVERSITY OF NOTRE DAME, RUTGERS STATE UNIVERSITY, STANFORD UNIVERSITY, AND UNIVERSITY OF WASHINGTON. THIS YEAR METAVIVOR WORKED ON PATIENT ADVOCACY ISSUES AND CONTINUED ITS NATIONWIDE PEER SUPPORT LEADER TRAINING PROGRAM. WE DEVELOPED NEW WEBSITE CAPABILITIES TO PROVIDE ONLINE RESOURCES TO SUPPORT THESE PROGRAMS AND TO SUPPORT OUR RESEARCH GRANT APPLICATION PROCESS. 6016909 true false false false false false false false false true true false false false true true true false false false false false false false true false false true false true false false false false false false false false false false false false false false false false false true 10 0 true 3 true false false false false false true true false false false false false false X 14 14 false false false false false false false true true false false true true true true true true true false false AK AL AR AZ CA CO CT DC FL GA HI IL KS KY LA MA MD ME MI MN MO MS NC ND NH NJ NM NV NY OH OK OR PA RI SC TN TX UT VA WA WI WV X X SONYA NEGLEY 8188601226 1783 FOREST DRIVE ANNAPOLIS MD 21401 SONYA NEGLEY EXECUTIVE DIRECTOR 040.00 X 153500 0 2500 JAMIL RIVERS PRESIDENT 010.00 X X 0 0 0 BARBARA BIGELOW VICE PRESIDENT 010.00 X X 0 0 0 KATE WATSON SECRETARY 009.00 X X 0 0 0 CJ DIAN CORNELIUSSEN-JAMES PAST PRESIDENT 009.00 X 0 0 0 SHARON ANDERSON DIRECTOR 009.00 X 0 0 0 NICOLE BECK DIRECTOR 009.00 X 0 0 0 JANICE COWDEN DIRECTOR 009.00 X 0 0 0 DAN CRAMER DIRECTOR 009.00 X 0 0 0 ALPHA LILLSTROM CHENG DIRECTOR 009.00 X 0 0 0 DR KELLY SHANAHAN DIRECTOR 009.00 X 0 0 0 PATTI STOUGH DIRECTOR 009.00 X 0 0 0 DR JILL BARGONETTI DIRECTOR 009.00 X 0 0 0 DR STUART MARTIN DIRECTOR 009.00 X 0 0 0 DR DANNY WELCH DIRECTOR 009.00 X 0 0 0 153500 2500 1 false true false 2542146 3591489 6133635 138655 138655 365889 2542146 365889 22669 22669 GRANTS REFUNDED 450000 450000 450000 6744959 450000 138655 5750000 5750000 0 0 0 156000 76439 76439 3122 0 25422 12457 12457 508 0 0 13118 6428 6428 262 0 0 28040 22993 5047 0 0 107393 88063 19330 16061 15740 321 40595 946 39649 0 0 0 9528 9528 0 50055 50055 0 0 17609 17609 8351 8351 COMMUNICATION 22256 22256 0 6244428 6016909 223306 4213 443981 886946 3588501 2397480 97404 75681 16723 20228 98664 91463 12001 7201 10902771 14041940 25758 12948 15087139 17442424 162084 167783 13140940 15203213 13303024 15370996 X 831872 1125055 952243 946373 1784115 2071428 15087139 17442424 500531 -213218 X false true X true false X 4470185 5437873 4892859 5723827 6156304 26681048 4470185 5437873 4892859 5723827 6156304 26681048 26681048 67950 220885 89962 53134 138655 570586 0 67950 220885 89962 53134 138655 570586 0 2030 2506 450000 454536 4538135 5658758 4984851 5779467 6744959 27706170 0.96300 0.98040 0.02060 0.01940 X false 101655 1513 103168 101645 10 101655 100608 1037 101645 100608 100608 100558 50 100608 0.99000 0.01000 false false 98664 91463 7201 7201 Financial derivatives and other financial products Closely-held equity interests Federal income taxes X 6447630 -213218 365889 152671 6294959 450000 450000 6744959 6160317 365889 365889 5794428 450000 450000 6244428 V 4 THE ENDOWMENT IS COMPRISED OF DONOR-RESTRICTED FUNDS. THE USE OF ENDOWMENT FUNDS THAT ARE DONOR-RESTRICTED FOR A SPECIFIC PURPOSE ARE STRICTLY RESTRICTED TO THAT PURPOSE. INCOME FROM THE SPECIFIED PURPOSE FUNDS MAY BE DISTRIBUTED ONLY FOR SUCH PURPOSE. ENDOWMENT FUNDS THAT ARE NOT SPECIFICALLY DIRECTED ARE PLACED IN THE GENERAL PURPOSE ENDOWMENT FUND. THE BOARD OF DIRECTORS, AT THEIR DISCRETION, MAY DISTRIBUTE THAT PORTION OF THE INCOME FROM THE GENERAL PURPOSE ENDOWMENT FUND FOR ANY PURPOSE CONSISTENT WITH THE TAX-EXEMPT ACTIVITIES OF THE ORGANIZATION. X 2 METAVIVOR RESEARCH AND SUPPORT, INC. IS EXEMPT FROM INCOME TAXES UNDER INTERNAL REVENUE CODE SECTION 501C3. IN ADDITION, THE ORGANIZATION HAS BEEN CLASSIFIED AS AN ORGANIZATION THAT IS NOT A PRIVATE ORGANIZATION UNDER SECTION 509A1. THE FEDERAL FORM 990, RETURN OF ORGANIZATION EXEMPT FROM INCOME TAX, IS SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE, GENERALLY FOR THREE YEARS AFTER IT IS FILED. XI 2D NET OF SPECIAL EVENTS OF 365,889 XI 4B REFUNDS OF GRANTS 450,000 XII 2D NET OF SPECIAL EVENTS OF 365,889 XII 4B REFUNDS OF GRANTS 450,000 METSQUERADE 2908035 2542146 365889 365889 2908035 2542146 365889 365889 365889 true UT HEALTH TEXAS MCGOVERN 6431 FANNIN HOUSTON TX 77030 741761309 501c3 250000 RESEARCH UNIVERSITY OF TEXAS ANDERSON 210 WEST 7TH STREET AUSTIN TX 78701 746001118 501c3 250000 RESEARCH ROSSWELL PARK COMPREHENSIVE CANCER CENTER 665 ELM STREET BUFFALO NY 14203 114140215 501c3 250000 RESEARCH RUSH UNIVERSITY 600 S PAULINA STREET CHICAGO IL 60612 362174823 501c3 250000 RESEARCH NEW YORK UNIVERSITY 50 WEST 4TH STREET NEW YORK NY 10012 135562308 501c3 250000 RESEARCH UNIVERSITY OF MARYLAND BALTIMORE 620 W LEXINGTON STREET BALTIMORE MD 21201 526002033 501c3 250000 RESEARCH UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL 5323 HARRY HINES BOULEVARD DALLAS TX 75390 752556007 501c3 250000 RESEARCH CITY OF HOPE NATIONAL MEDICAL CENTER 1420 WALNUT STREET PHILADELPHIA PA 19102 953435919 501c3 250000 RESEARCH UNIVERSITY OF TEXAS ANDERSON 210 WEST 7TH STREET AUSTIN TX 78701 746001118 501c3 250000 RESEARCH UNIVERSITY OF STANFORD 450 JANE STANFORD WAY STANFORD CA 94305 941156365 501c3 250000 RESEARCH CASE WESTERN UNIVERSITY 10900 EUCLID AVENUE CLEAVELAND OH 44106 341018992 501c3 250000 RESEARCH UNIVERSITY OF SOUTHERN CALIFORNIA KECK SCHOOL OF MEDICINE USC NORRIS COMPRE 3720 S FLOWER STREET LOS ANGELES CA 90089 951642394 501c3 250000 RESEARCH LOMBARDI COMPREHENSIVE CANCER CENTER 3800 RESERVOIR ROAD NW WASHINGTON DC 20007 153019660 501c3 250000 RESEARCH ROSSWELL PARK COMPREHENSIVE CANCER CENTER 665 ELM STREET BUFFALO NY 14203 114140215 501c3 250000 RESEARCH UNIVERSITY OF MIAMI 1320 S DIXIE HIGHWAY CORAL GABLES FL 33146 590624458 501c3 250000 RESEARCH HOUSTON METHODIST 6565 FANNIN STREET HOUSTON TX 77030 741180155 501c3 250000 RESEARCH WAKE FOREST 1834 WAKE FOREST ROAD WINSTONSALEM NC 27109 560532138 501c3 250000 RESEARCH MEMORIAL SLOAN KETTERING CANCER CENTER 1275 YORK AVENUE NEW YORK NY 10065 131924236 501c3 250000 RESEARCH UNIVERSITY OF NOTRE DAME 220 MAIN BUILDING NOTRE DAME IN 46556 350868188 501c3 250000 RESEARCH GEORGETOWN UNIVERSITY 3700 O STREET NW WASHINGTON DC 20057 530196603 501c3 100000 RESEARCH UNIVERSITY OF WISCONSIN MADISON 600 HIGHLAND AVENUE MADISON WI 53792 255017177 501c3 100000 RESEARCH TEMPLE UNIVERSITY 1330 POLLET WALK PHILADELPHIA PA 19122 231365971 501c3 100000 RESEARCH UNIVERSITY OF STANFORD 450 JANE STANFORD WAY STANFORD CA 94305 941156365 501c3 100000 RESEARCH UNIVERSITY OF PITTSBURGH 4200 FIFTH AVENUE PITTSBURGH PA 15260 250966591 501c3 100000 RESEARCH MOFFITT CANCER CENTER 12902 MAGNOLIA DRIVE TAMPA FL 33612 593238634 501c3 100000 RESEARCH UNIVERSITY OF MARYLAND BALTIMORE 620 W LEXINGTON STREET BALTIMORE MD 21201 526002033 501c3 200000 RESEARCH UNIVERSITY OF KANSAS MEDICAL CENTER RESEARCH INSTITUTE 4330 SHAWNEE MISSION PARKWAY FAIRWAY KS 66205 481108830 501c3 200000 RESEARCH 27 Part I Line 2 METAVIVOR GRANTS ARE AWARDED TO ESTABLISHED AND EARLY CAREER RESEARCHERS WITH MD AND/OR PHD DEGREES IN RELEVANT FIELDS, WHO ARE CONDUCTING RESEARCH AT ACCREDITED COLLEGES AND UNIVERSITIES, OR OTHER RESPECTED RESEARCH INSTITUTIONS SUCH AS THE NATIONAL CANCER INSTITUTE. GRANT AWARDEES ARE CHOSEN BASED ON A RIGOROUS PEER REVIEW PROCESS WHEREIN PROPOSALS ARE SCORED BASED ON RESEARCH MERIT, BUDGET, SUITABILITY OF FACILITIES, AND OTHER CRITERIA. SELECTION CRITERIA ARE DOCUMENTED FOR EACH GRANT CYCLE IN THE PUBLICLY RELEASE REQUEST FOR PROPOSALS. AWARDED GRANTS ARE MONITORED FOR APPROPRIATE USE OF FUNDS AT LEAST QUARTERLY. SECOND YEAR FUNDING IS CONTINGENT UPON ACCEPTANCE BY THE BOARD OF DIRECTORS OF A YEAR ONE PROGRESS REPORT. X X false false false false false false false false false SONYA NEGLEY EXECUTIVE DIRECTOR 153500 2500 156000 Form 990, Part VI, Line 11 A DRAFT OF THE FORM 990 IS PROVIDED TO THE BOARD FOR REVIEW PRIOR TO FILING. Form 990, Part VI, Line 12C THE BOARD OF DIRECTORS REQUIRES EACH INTERESTED PERSON TO DISCLOSE ANY FINANCIAL INTEREST IN, OR ROLE IN THE GOVERNANCE OF, ANY OTHER CORPORATION, FIRM, ASSOCIATION, OR OTHER ENTITY CONTRACTING OR ENGAGING IN ANY OTHER TRANSACTION WITH METAVIVOR. AS SOON AS IS PRACTICABLE AFTER DETERMINING THAT A POTENTIAL CONFLICT OF INTEREST EXISTS, THE BOARD OF DIRECTORS SHALL FIRST DELIBERATE THE MATTER AFTER THE POTENTIALLY INTERESTED PERSON SUPPLIES SUCH INFORMATION AS THE BOARD OF DIRECTORS SHALL REQUEST, RECUSES HIMSELF OR HERSELF, AND LEAVES THE MEETING, AND THEN THE BOARD OF DIRECTORS SHALL DECIDE IF A CONFLICT OF INTEREST EXISTS. IN THE CASE OF ALL COMPENSATION ARRANGEMENTS AND ALL OTHER ARRANGEMENTS WHERE THE BOARD OF DIRECTORS DETERMINES THAT THERE IS A CONFLICT, THE BOARD OF DIRECTORS SHALL A. REQUIRE THAT THE INTERESTED PERSON LEAVE THE MEETING DURING THE DISCUSSION OF, AND THE VOTE ON, THE TRANSACTION OR ARRANGEMENT THAT MAY CREATE THE CONFLICT OF INTEREST AND B. ENTER INTO THE TRANSACTION ONLY IF THE BOARD OF DIRECTORS DETERMINES, BY A MAJORITY VOTE OF THE NON-INTERESTED DIRECTORS THEN IN OFFICE, THAT THE TRANSACTION OR ARRANGEMENT IS IN METAVIVORS BEST INTERESTS AND FOR ITS OWN BENEFIT IS FAIR AND REASONABLE TO METAVIVOR AND, AFTER EXERCISING DUE DILIGENCE, DETERMINES THAT METAVIVOR CANNOT OBTAIN A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT WITH REASONABLE EFFORTS UNDER THE CIRCUMSTANCES. Form 990, Part VI, Line 12C THE MINUTES OF THE BOARD OF DIRECTORS MEETINGS AND THE MEETINGS OF ANY COMMITTEE WITH BOARD-DELEGATED POWERS SHALL INCLUDE 1. THE NAME OF EACH PERSON WHO DISCLOSES AN INTEREST, THE NATURE OF THAT INTEREST, AND WHETHER THE BOARD OF DIRECTORS HAS DETERMINED THAT THERE IS A CONFLICT OF INTEREST 2. COPIES OF ALL DOCUMENTS DESCRIBING THE OTHER ALTERNATIVES TO THE PROPOSED TRANSACTION, COMPARABLE SALARIES, AND ANY OTHER DUE DILIGENCE APPROPRIATE TO THE TRANSACTION AND 3. THE NAMES OF THE PERSONS WHO WERE PRESENT FOR DISCUSSIONS AND VOTES RELATING TO THE TRANSACTION OR ARRANGEMENT AND THE CONTENT OF THOSE DISCUSSIONS, INCLUDING ANY ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT, AND A RECORD OF THE VOTE. THE BOARD OF DIRECTORS SHALL ENSURE THAT THIS POLICY IS DISTRIBUTED TO ALL INTERESTED PERSONS. EACH SUCH PERSON SHALL SIGN AN ANNUAL STATEMENT, IN THE FORM ATTACHED HERETO, THAT THE PERSON 1. RECEIVED A COPY OF THE POLICY 2. HAS READ AND UNDERSTANDS THE POLICY 3. AGREES TO COMPLY WITH THE POLICY 4. UNDERSTANDS THAT THE POLICY APPLIES TO ALL COMMITTEES AND SUBCOMMITTEES HAVING BOARD-DESIGNATED POWERS AND 5. UNDERSTANDS THAT METAVIVOR IS A CHARITABLE ORGANIZATION AND THAT IN ORDER TO MAINTAIN ITS TAX EXEMPT STATUS, IT MUST EXCLUSIVELY ENGAGE IN ACTIVITIES WHICH ARE DIRECTED TOWARDS THE ACCOMPLISHMENT OF ONE OR MORE OF ITS TAX-EXEMPT PURPOSES. Form 990, Part VI, Line 15A THE BYLAWS OF METAVIVOR RESEARCH AND SUPPORT INC. ESTABLISH A COMPENSATION COMMITTEE THAT HAS GENERAL OVERSIGHT OF THE ORGANIZATIONS HUMAN RESOURCE PLAN. SPECIFIC DUTIES INCLUDE YEARLY EVALUATION OF THE EXECUTIVE DIRECTOR OF THE ORGANIZATION. A COMPETENT SALARY SURVEY IS USED TO BENCHMARK THE COMPENSATION FOR THE POSITION UTILIZING INDUSTRY-SPECIFIC REPORTS AND OTHER STUDIES. THE COMMITTEE MEETS INDEPENDENTLY OF THE CHIEF EXECUTIVE TO DISCUSS PERFORMANCE RELATIVE TO THE POSITION DESCRIPTION. DURING THESE DELIBERATIONS, THE COMMITTEE ALSO CONSIDERS INPUT OBTAINED FROM OTHER BOARD MEMBERS, STAFF, PROFESSIONAL ADVISORS, GRANT RECIPIENTS, AND OTHER INFORMED COMMUNITY LEADERS. THESE DISCUSSIONS ARE DOCUMENTED CONTEMPORANEOUSLY IN WRITING. ONCE A CONSENSUS IS REACHED REGARDING PERFORMANCE A SIMILAR DISCUSSION IS HELD CONCERNING COMPENSATION RELATIVE TO ANNUAL BENCHMARK AND ESTABLISHED OBJECTIVES. THE COMMITTEE PRESENTS ITS FINDINGS AND RECOMMENDATIONS, IN AN EXECUTIVE SESSION WITHOUT THE CHIEF EXECUTIVE PRESENT, TO THE FULL BOARD FOR REVIEW AND APPROVAL. THE COMMITTEE AND/OR BOARD CHAIR A MEMBER OF THE COMMITTEE THEN MEET WITH THE CHIEF EXECUTIVE OFFICER TO DISCUSS AND DOCUMENT STRENGTHS, WEAKNESSES, AND GOALS FOR THE UPCOMING YEAR. COMPENSATION FOR THE UPCOMING YEAR IS ALSO DISCUSSED AND DOCUMENTED. THESE DISCUSSIONS ARE DOCUMENTED CONTEMPORANEOUSLY IN WRITING. Form 990, Part VI, Line 19 A DRAFT OF THE FORM 990 IS PROVIDED TO THE BOARD FOR REVIEW PRIOR TO FILING. Form 990, Part I, Line 1 MISSION STATEMENT-PROVIDE SUPPORT AND EDUCATION FOR PATIENTS LIVING WITH MBC AND PROMOTE AWARENESS OF MBC TO INCREASE RESEARCH FUNDING. TO FUND STAGE IV METASTATIC BREAST CANCER MBC RESEARCH TO TRANSITION THE DISEASE FROM TERMINAL TO CHRONIC YET MANAGEABLE WITH A GOOD QUALITY OF LIFE, PROVIDE SUPPORT AND EDUCATION FOR PATIENTS LIVING WITH MBC AND PROMOTE AWARENESS OF MBC TO INCREASE RESEARCH FUNDING.